Jade Biosciences, Inc.

JBIO

JBIOJade Biosciences, Inc. US flag

NASDAQ Global Market

20.95

USD

-1.53

- -

683.51MMarket Cap

Income Statement (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Sales/Revenue/Turnover	- -	- -
+ Sales & Services Revenue	- -	- -
- Cost of Revenue	- -	- -
+ Cost of Goods & Services	- -	- -
Gross Profit	- -	- -
+ Other Operating Income	- -	- -
- Operating Expenses	- -	114
+ Selling, General & Admin	- -	20
+ Research & Development	- -	93
+ Other Operating Expense	- -	- -
Operating Income (Loss)	- -	-114
- Non-Operating (Income) Loss	- -	14
+ Interest Expense, Net	- -	-8
+ Interest Expense	- -	- -
- Interest Income	- -	8
+ Other Non-Op (Income) Loss	- -	22
Pretax Income	- -	-127
- Income Tax Expense (Benefit)	- -	- -
- (Income) Loss from Affiliates	- -	- -
Income (Loss) from Cont Ops	- -	-127
- Net Extraordinary Losses (Gains)	- -	- -
+ Discontinued Operations	- -	- -
+ Extraord. & Accounting Changes	- -	- -
Income (Loss) Incl. MI	- -	-127
- Minority Interest	- -	- -
Net Income, GAAP	- -	-127
- Preferred Dividends	- -	- -
- Other Adjustments	- -	- -
Net Income Avail to Common, GAAP	- -	-127
EBIT	- -	-114
EBITDA	- -	-114
EBITDA Margin (%)	- -	- -
EBITA	- -	-114
Gross Margin (%)	- -	- -
Operating Margin (%)	- -	- -
Profit Margin (%)	- -	- -
Sales per Employee	- -	- -
Dividend per Share	- -	- -
Depreciation Expense	- -	- -
Basic Weighted Avg Shares	- -	31
Basic EPS, GAAP	- -	-4.06
Basic EPS from Cont Ops	- -	-4.06
Diluted Weighted Avg Shares	- -	31
Diluted EPS, GAAP	- -	-4.06
Diluted EPS from Cont Ops	- -	-4.06

Balance Sheet (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Total Current Assets	70	349
+ Cash, Cash Equivalents & STI	69	336
+ Cash & Cash Equivalents	69	88
+ ST Investments	- -	248
+ Accounts & Notes Receiv	- -	- -
+ Accounts Receivable, Net	- -	- -
+ Notes Receivable, Net	- -	- -
+ Loans Receivable, Net	- -	- -
+ Other Receivable, Net	- -	- -
+ Inventories	- -	- -
+ Raw Materials	- -	- -
+ Work In Process	- -	- -
+ Finished Goods	- -	- -
+ Inventory Adjustments	- -	- -
+ Other Inventory	- -	- -
+ Other ST Assets	- -	13
+ Misc ST Assets	- -	- -
+ Prepaid Expenses	- -	- -
+ ST Derivative & Hedging Assets	- -	- -
+ ST Assets Held-for-Sale	- -	- -
+ ST Deferred Tax Assets	- -	- -
Total Noncurrent Assets	3	1
+ Property, Plant & Equip, Net	- -	1
+ Property, Plant & Equip	- -	1
- Accumulated Depreciation	- -	- -
+ LT Investments & Receivables	- -	- -
+ LT Investments	- -	- -
+ LT Receivables	- -	- -
+ Other LT Assets	3	- -
+ Total Intangible Assets	- -	- -
+ Goodwill	- -	- -
+ Other Intangible Assets	- -	- -
+ LT Deferred Tax Assets	- -	- -
+ LT Derivative & Hedging Assets	- -	- -
+ Misc LT Assets	3	- -
Total Assets	73	350
+ Payables & Accruals	8	13
+ Accounts Payable	1	2
+ Accrued Taxes	- -	- -
+ Interest & Dividends Payable	- -	- -
+ Other Payables & Accruals	7	11
+ ST Debt	- -	- -
+ ST Borrowings	- -	- -
+ ST Finance Leases	- -	- -
+ Other ST Liabilities	4	3
+ Deferred Revenue	- -	- -
+ Derivatives & Hedging	- -	- -
+ Deferred Tax Liabilities	- -	- -
+ Misc ST Liabilities	4	3
Total Current Liabilities	12	17
+ LT Debt	108	1
+ LT Borrowings	108	- -
+ LT Finance Leases	- -	1
+ Other LT Liabilities	- -	- -
+ Accrued Liabilities	- -	- -
+ Pension Liabilities	- -	- -
+ Deferred Revenue	- -	- -
+ Deferred Tax Liabilities	- -	- -
+ Derivatives & Hedging	- -	- -
+ Misc LT Liabilities	- -	- -
Total Noncurrent Liabilities	108	1
Total Liabilities	120	17
+ Preferred Equity and Hybrid Capital	- -	- -
+ Share Capital & APIC	- -	507
+ Common Stock	- -	- -
+ Additional Paid in Capital	- -	507
- Treasury Stock	- -	- -
+ Retained Earnings	-47	-174
+ Other Equity	- -	- -
Equity Before Minority Interest	-47	333
+ Minority/Non Controlling Interest	- -	- -
Total Equity	-47	333
Total Liabilities & Equity	73	350
Shares Outstanding	32	49
Number of Employees	- -	- -
Capital Leases - Total	- -	1
Net Debt	38	-88
Net Debt to Equity	-81.66	-26.6
Tangible Common Equity Ratio	-64.29	95.06
Current Ratio	5.81	21.09
Cash Conversion Cycle	- -	- -

Cash Flow Statement (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

+ Net Income	- -	-127
+ Depreciation & Amortization	- -	- -
+ Non-Cash Items	- -	41
+ Stock-Based Compensation	- -	20
+ Deferred Income Taxes	- -	- -
+ Asset Impairment Charge	- -	- -
+ Other Non-Cash Adj	- -	21
+ Chg in Non-Cash Work Cap	- -	-8
+ (Inc) Dec in Accts Receiv	- -	- -
+ (Inc) Dec in Inventories	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	-12
+ Inc (Dec) in Accts Payable	- -	4
+ Inc (Dec) in Other	- -	- -
+ Net Cash From Disc Ops	- -	- -
Cash from Operating Activities	- -	-95
+ Change in Fixed & Intang	- -	- -
+ Disp in Fixed & Intang	- -	- -
+ Disp of Fixed Prod Assets	- -	- -
+ Disp of Intangible Assets	- -	- -
+ Acq of Fixed & Intang	- -	- -
+ Acq of Fixed Prod Assets	- -	- -
+ Acq of Intangible Assets	- -	- -
+ Cash (Repurchase) of Equity	- -	189
+ Increase in Capital Stock	- -	189
+ Decrease in Capital Stock	- -	- -
+ Net Change in LT Investment	- -	-247
+ Dec in LT Investment	- -	14
+ Inc in LT Investment	- -	-261
+ Net Cash From Acq & Div	- -	- -
+ Cash from Divestitures	- -	- -
+ Cash for Acq of Subs	- -	- -
+ Cash for JVs	- -	- -
+ Other Investing Activities	- -	- -
+ Net Cash From Disc Ops	- -	- -
Cash from Investing Activities	- -	-247
+ Dividends Paid	- -	- -
+ Net Cash From Debt	- -	- -
+ Cash From Debt	- -	- -
+ Repayments of Debt	- -	- -
+ Other Financing Activities	- -	172
+ Net Cash From Disc Ops	- -	- -
Cash from Financing Activities	- -	361
Effect of Foreign Exchange Rates	- -	- -
Net Changes in Cash	- -	19
EBITDA	- -	-114
EBITDA Margin (%)	- -	- -
Free Cash Flow	- -	-95
Net Cash Paid for Acquisitions	- -	- -
Free Cash Flow to Firm	- -	- -
Free Cash Flow to Equity	- -	-95
Free Cash Flow per Basic Share	- -	-3.03
Price/Free Cash Flow	- -	-5.12
Cash Flow to Net Income	- -	0.74
Capital Expenditures	- -	- -